Injective trades in narrow band while RSI hints at bearish bias: weekly review

Injective trades in narrow band while RSI hints at bearish bias: weekly review
Injective gains 4.88% this week

Injective (INJ) is currently trading at $4.98, having gained $0.23 or 4.88% over the past week. The asset is positioned above its weekly MA-20 ($4.15), indicating some medium-term buying interest, but it remains below both the MA-50 ($6.43) and MA-200 ($13.15), highlighting ongoing longer-term selling pressure.

INJ price prediction
24H -2.58%
$4.91
48H 0.99%
$5.09
7D 2.18%
$5.15
1M -11.71%
$4.45
3M 12.1%
$5.65
6M -16.47%
$4.21
12M 165.67%
$13.39
Current price: $ 5.04 0.41 8.74%
Real-time Data 21:38
Daily range 4.67 Arrow from to Icon 5.13
Weekly range 4.53 Arrow from to Icon 5.15
Loading...

Highlights

  • Injective (INJ) trades above short-term averages but remains under longer-term resistance, signaling uncertain directional bias.
  • Technical momentum and trend indicators are mixed to weak, indicating the lack of a clear bullish or bearish conviction.
  • INJ is expected to move between $4.81 and $5.13 this week, with downside risk outweighing any breakout potential.

Mixed technical momentum as weak trend counters mild buying

Weekly technical indicators reveal mixed momentum for INJ. The MACD signals a strong sell and the ADX at 19.91 points to a lack of trend strength, while the RSI at 47.21 maintains a slightly bearish bias. Stochastic RSI and CCI both remain neutral, and Bull/Bear Power is positive at 0.29, reflecting a slight presence of buyers this week. Key support sits near $4.81, and resistance is found at $5.13, framing the upper and lower bounds of the weekly trading corridor.

Injective asset chart
Injective price dynamics. Source: TradingView.

Rangebound outlook as buy signals scarce for the coming week

Looking forward to the next 7 days, INJ is likely to trade between $4.81 and $5.13. With none of the four main weekly indicators signaling a buy, the probability of a sustained upward move remains below 20%. The asset is expected to remain rangebound as short-term buyers support prices above $4.81, but a move above $5.13 appears unlikely unless momentum shifts. A break below support could see renewed selling pressure and lead to further downside.

Viktoras Karapetjanc, expert at Traders Union, sees Injective’s solid 4.88% gain this week and resilience above the MA-20 as signals of renewed buyer interest in a challenging environment. He notes that, while INJ faces persistent long-term selling pressure with both MA-50 and MA-200 overhead, the ability to recover from recent lows and hold the upper weekly range is constructive. Mixed momentum readings do not favor a breakout, but Karapetjanc believes the coming week still holds notable opportunity for active traders if support at $4.81 is respected. He remains attentive to broader crypto sentiment, highlighting that rangebound setups often lead to sharp directional moves as volatility clusters. "As long as Injective holds above support, I see continued potential for bullish structures to emerge — this week’s setup rewards patient accumulation within the current corridor."

Earlier, analysts noted that improving sentiment and technical advances were supporting a shift away from medium-term bearishness in Injective. However, with key weekly indicators now showing mixed momentum and the asset trading below long-term moving averages, traders should watch for a decisive break above $5.13 to confirm any sustainable trend reversal.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.